DANBURY, Conn., Aug. 8, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) announced today that management will be presenting an overview of the company's technologies, development programs, and outlook at the Wedbush 2013 Life Sciences Management Access Conference in New York City on August 13, 2013 at 10:20 AM Eastern Daylight Time.
A live and archived webcast of the presentation will be accessible on the Biodel website at www.biodel.com under "Webcasts" in the "News & Events" section.
About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles. More information about Biodel is available at www.biodel.com.
BIOD-G